REVIEWS

Histological patterns in drug-induced liver disease

R Ramachandran¹, S Kakar²

¹ Department of Pathology, University of California, San Francisco, California, USA
² Department of Pathology, University of California, San Francisco, and Veterans Affairs Medical Center, San Francisco, California, USA

Correspondence to:
Dr Sanjay Kakar, Department of Pathology, UCSF and VA Medical Center, San Francisco, CA 94143, USA; sanjay.kakar{at}ucsf.edu

The diagnosis of drug-induced liver injury (DILI) is a challenging problem, often confounded by incomplete clinical information and the difficulty of eliciting exposure to herbal products, over-the-counter agents and toxins. The task is further rendered difficult on biopsy, as drugs can mimic all the patterns found in primary liver disease. Acute hepatitis, with or without cholestasis, is the most common histological pattern of DILI, and drugs such as acetaminophen are the leading causes of acute liver failure. Most cases of DILI resolve on discontinuation of the drug, but recovery can take months or rarely the disease can progress despite drug withdrawal. Drugs such as methotrexate can lead to chronic hepatitis and cirrhosis, while others such as minocycline, nitrofurantoin and methyldopa are implicated in autoimmune hepatitis. Prolonged cholestasis and ductopenia resembling primary chronic biliary disease can occur. Drug-induced steatohepatitis is also an uncommon pattern, but is well described with drugs such as amiodarone and irinotecan. In the presence of risk factors such as obesity and diabetes, some drugs such as tamoxifen, oestrogens and nifedipine can precipitate or exacerbate steatohepatitis. Other observed patterns include granulomatous hepatitis, vascular injury (eg, sinusoidal obstruction syndrome), Ito cell lipidosis and neoplasms (eg, adenomas).

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?